Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

ProQR Therapeutics N.V (PRQR) Gross Profit: 2021-2025

Historic Gross Profit for ProQR Therapeutics N.V (PRQR) over the last 5 years, with Sep 2025 value amounting to $3.4 million.

  • ProQR Therapeutics N.V's Gross Profit fell 20.17% to $3.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $17.0 million, marking a year-over-year decrease of 12.03%. This contributed to the annual value of $20.2 million for FY2024, which is 186.70% up from last year.
  • ProQR Therapeutics N.V's Gross Profit amounted to $3.4 million in Q3 2025, which was down 22.02% from $4.3 million recorded in Q2 2025.
  • In the past 5 years, ProQR Therapeutics N.V's Gross Profit registered a high of $6.8 million during Q2 2024, and its lowest value of $170,079 during Q1 2021.
  • Over the past 3 years, ProQR Therapeutics N.V's median Gross Profit value was $4.2 million (recorded in 2024), while the average stood at $3.6 million.
  • Its Gross Profit has fluctuated over the past 5 years, first spiked by 645.68% in 2022, then crashed by 44.57% in 2023.
  • ProQR Therapeutics N.V's Gross Profit (Quarterly) stood at $273,409 in 2021, then soared by 168.67% to $734,578 in 2022, then skyrocketed by 381.01% to $3.5 million in 2023, then spiked by 30.26% to $4.6 million in 2024, then decreased by 20.17% to $3.4 million in 2025.
  • Its Gross Profit was $3.4 million in Q3 2025, compared to $4.3 million in Q2 2025 and $4.8 million in Q1 2025.